Article Type
Changed
Display Headline

Rupioid Id Reaction With Peripheral Eosinophilia

To the Editor:

In dermatology, rupioid describes ­dirty-appearing scale. The term is derived from the Greek word rhupos, which translates to “dirty” or “filthy.” This type of scale also is called ostraceous, owing to its resemblance to an oyster shell. Histopathologically, rupioid or ostraceous scale corresponds to epidermal hyperplasia and hyperkeratosis. Therefore, the presence of rupioid scale is believed to reflect an exuberant inflammatory response. Several dermatologic conditions have been associated with rupioid scale, including psoriasis, secondary syphilis, reactive arthritis, histoplasmosis, and Norwegian scabies.1-4 Peripheral eosinophilia has been reported in eczematous dermatoses such as atopic dermatitis and contact dermatitis,5,6 but our review of the literature did not find it described in the context of id reactions. We report the case of a patient who developed a rupioid id reaction with peripheral eosinophilia.

An otherwise healthy 40-year-old woman presented with a generalized pruritic eruption of 1 month’s duration. Prior to onset, she was bitten by a bug on the left arm and covered the site with a bandage. She subsequently noticed an erythematous papulopustular rash corresponding to the shape of the bandage adhesive. Shortly thereafter, a generalized eruption developed, prompting the patient to present for evaluation 1 month later. A review of systems was negative for fevers, chills, headaches, vision changes, and joint symptoms. She denied having a history of atopy.

Physical examination revealed numerous pink papules and plaques with rupioid scale scattered over the trunk and extremities (Figure). The palms, soles, and mucous membranes were spared. Laboratory studies revealed peripheral eosinophilia (9% eosinophils [reference range, 1%-6%] and an absolute eosinophil count of 600/µL [reference range, 0-400/µL]). A 3-mm punch biopsy of a representative lesion revealed a superficial perivascular infiltrate of lymphocytes, histiocytes, and eosinophils along with epidermal hyperplasia, spongiosis, and mounds of parakeratosis. Clinicopathologic correlation led to the diagnosis of a rupioid id reaction secondary to an arthropod assault and/or a reaction to the bandage adhesive.

CT117001014_e-FigAB
FIGURE. A and B, Rupioid id reaction secondary to an arthropod assault and/or a reaction to a bandage adhesive. Papules and plaques with rupioid scale were present on the back and left arm.

Treatment with topical corticosteroids was avoided at the patient’s request. Instead, a ceramide-based emollient and oral antihistamines (fexofenadine 180 mg in the morning and cetirizine 10 mg in the evening) were recommended and resulted in resolution of the eruption with postinflammatory hyperpigmentation at 2-week follow-up. The patient was advised to avoid further exposure to bandage adhesives.

An id reaction, or autoeczematization, is a cutaneous immunologic response to antigen(s) released from an initial, often distant site of inflammation.7,8 Clinically, it typically manifests as a pruritic, symmetrically distributed papulovesicular eruption. Although the pathogenesis of id reactions is uncertain, overactivation of T lymphocytes responding to the initial inflammatory insult has been implicated.7 A variety of noninfectious (eg, stasis dermatitis, contact dermatitis) and infectious dermatoses (eg, fungal, bacterial, viral, parasitic) may trigger id reactions.7,9-13 In this case, we believe an arthropod assault and/or reaction to the bandage adhesive was the primary insult, and the id reaction that ensued was so exuberant that it resulted not only in rupioid scale but also in peripheral eosinophilia—similar to how more severe forms of atopic dermatitis have been associated with peripheral eosinophilia.5 As such presentations of id reactions not have been widely described in the literature, this report expands our understanding of this condition to include rupioid scale and peripheral eosinophilia.

References
  1. Chung HJ, Marley-Kemp D, Keller M. Rupioid psoriasis and other skin diseases with rupioid manifestations. Cutis. 2014;94:119-121.
  2. Costa JB, de Sousa VLLR, da Trindade Neto PB, et al. Norwegian scabies mimicking rupioid psoriasis. An Bras Dermatol. 2012;87:910-913. doi:10.1590/S0365-05962012000600016
  3. Ip KH-K, Cheng HS, Oliver FG. Rupioid psoriasis. JAMA Dermatol. 2021;157:859. doi:10.1001/jamadermatol.2021.0451
  4. Wang Y, Wen Y. An AIDS patient with recurrent multiple skin crusted ulcerations. AIDS Res Hum Retroviruses. 2021;37:1-3. doi:10.1089/aid.2020.0212
  5. Staumont-Sallé D, Barbarot S, Bouaziz JD, et al. Effect of abrocitinib and dupilumab on eosinophil levels in patients with moderate-to-severe atopic dermatitis. JEADV Clin Pract. 2023;2:518-530. doi:10.1002/jvc2.192
  6. Savjani P. An unusual cause of eosinophilia—hypereosinophilia due to contact dermatitis. J Allergy Clin Immunol. 2016;137:AB168. doi:10.1016/j.jaci.2015.12.685
  7. Bertoli M, Schwartz RA, Janniger CK. Autoeczematization: a strange id reaction of the skin. Cutis. 2021;108:163-166. doi:10.12788/cutis.0342
  8. Ilkit M, Durdu M, Karakas¸ M. Cutaneous id reactions: a comprehensive review of clinical manifestations, epidemiology, etiology, and management. Crit Rev Microbiol. 2012;38:191-202. doi:10.3109/1040841X.2011.645520
  9. Brenner S, Wolf R, Landau M. Scabid: an unusual id reaction to scabies. Int J Dermatol. 1993;32:128-129. doi:10.1111/j.1365-4362.1993.tb01454.x
  10. Jordan L, Jackson NAM, Carter-Snell B, et al. Pustular tinea id reaction. Cutis. 2019;10:E3-E4.
  11. Crum N, Hardaway C, Graham B. Development of an idlike reaction during treatment for acute pulmonary histoplasmosis: a new cutaneous manifestation in histoplasmosis. J Am Acad Dermatol. 2003;48(2 suppl):S5-S6. doi:10.1067/mjd.2003.110
  12. Netchiporouk E, Cohen BA. Recognizing and managing eczematous id reactions to molluscum contagiosum virus in children. Pediatrics. 2012;129:e1072-e1075. doi:10.1542/peds.2011-1054
  13. Choudhri SH, Magro CM, Crowson AN, et al. An id reaction to Mycobacterium leprae: first documented case. Cutis. 1994;54:282-286.
Article PDF
Author and Disclosure Information

Devyn Zaminski and Dr. Mazori are from the Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York. Dr. Richardson is from the Department of Dermatology, SUNY Downstate Health Sciences University, Brooklyn, New York. Dr. Celen is from the Division of Dermatology, Department of Medicine, Robert Wood Johnson Medical School, New Brunswick, New Jersey. Dr. Freedman is from Suncoast Skin Solutions, Jupiter, Florida. Dr. Meehan is from the Kimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York.

The authors have no relevant financial disclosures to report.

Correspondence: Daniel R. Mazori, MD, The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, 222 East 41st St, 16th Floor, New York, NY 10017 ([email protected]).

Cutis. 2026 January;117(1):E14-E15. doi:10.12788/cutis.1324

Issue
Cutis - 117(1)
Publications
Topics
Page Number
E14-E15
Sections
Author and Disclosure Information

Devyn Zaminski and Dr. Mazori are from the Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York. Dr. Richardson is from the Department of Dermatology, SUNY Downstate Health Sciences University, Brooklyn, New York. Dr. Celen is from the Division of Dermatology, Department of Medicine, Robert Wood Johnson Medical School, New Brunswick, New Jersey. Dr. Freedman is from Suncoast Skin Solutions, Jupiter, Florida. Dr. Meehan is from the Kimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York.

The authors have no relevant financial disclosures to report.

Correspondence: Daniel R. Mazori, MD, The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, 222 East 41st St, 16th Floor, New York, NY 10017 ([email protected]).

Cutis. 2026 January;117(1):E14-E15. doi:10.12788/cutis.1324

Author and Disclosure Information

Devyn Zaminski and Dr. Mazori are from the Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York. Dr. Richardson is from the Department of Dermatology, SUNY Downstate Health Sciences University, Brooklyn, New York. Dr. Celen is from the Division of Dermatology, Department of Medicine, Robert Wood Johnson Medical School, New Brunswick, New Jersey. Dr. Freedman is from Suncoast Skin Solutions, Jupiter, Florida. Dr. Meehan is from the Kimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York.

The authors have no relevant financial disclosures to report.

Correspondence: Daniel R. Mazori, MD, The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, 222 East 41st St, 16th Floor, New York, NY 10017 ([email protected]).

Cutis. 2026 January;117(1):E14-E15. doi:10.12788/cutis.1324

Article PDF
Article PDF

To the Editor:

In dermatology, rupioid describes ­dirty-appearing scale. The term is derived from the Greek word rhupos, which translates to “dirty” or “filthy.” This type of scale also is called ostraceous, owing to its resemblance to an oyster shell. Histopathologically, rupioid or ostraceous scale corresponds to epidermal hyperplasia and hyperkeratosis. Therefore, the presence of rupioid scale is believed to reflect an exuberant inflammatory response. Several dermatologic conditions have been associated with rupioid scale, including psoriasis, secondary syphilis, reactive arthritis, histoplasmosis, and Norwegian scabies.1-4 Peripheral eosinophilia has been reported in eczematous dermatoses such as atopic dermatitis and contact dermatitis,5,6 but our review of the literature did not find it described in the context of id reactions. We report the case of a patient who developed a rupioid id reaction with peripheral eosinophilia.

An otherwise healthy 40-year-old woman presented with a generalized pruritic eruption of 1 month’s duration. Prior to onset, she was bitten by a bug on the left arm and covered the site with a bandage. She subsequently noticed an erythematous papulopustular rash corresponding to the shape of the bandage adhesive. Shortly thereafter, a generalized eruption developed, prompting the patient to present for evaluation 1 month later. A review of systems was negative for fevers, chills, headaches, vision changes, and joint symptoms. She denied having a history of atopy.

Physical examination revealed numerous pink papules and plaques with rupioid scale scattered over the trunk and extremities (Figure). The palms, soles, and mucous membranes were spared. Laboratory studies revealed peripheral eosinophilia (9% eosinophils [reference range, 1%-6%] and an absolute eosinophil count of 600/µL [reference range, 0-400/µL]). A 3-mm punch biopsy of a representative lesion revealed a superficial perivascular infiltrate of lymphocytes, histiocytes, and eosinophils along with epidermal hyperplasia, spongiosis, and mounds of parakeratosis. Clinicopathologic correlation led to the diagnosis of a rupioid id reaction secondary to an arthropod assault and/or a reaction to the bandage adhesive.

CT117001014_e-FigAB
FIGURE. A and B, Rupioid id reaction secondary to an arthropod assault and/or a reaction to a bandage adhesive. Papules and plaques with rupioid scale were present on the back and left arm.

Treatment with topical corticosteroids was avoided at the patient’s request. Instead, a ceramide-based emollient and oral antihistamines (fexofenadine 180 mg in the morning and cetirizine 10 mg in the evening) were recommended and resulted in resolution of the eruption with postinflammatory hyperpigmentation at 2-week follow-up. The patient was advised to avoid further exposure to bandage adhesives.

An id reaction, or autoeczematization, is a cutaneous immunologic response to antigen(s) released from an initial, often distant site of inflammation.7,8 Clinically, it typically manifests as a pruritic, symmetrically distributed papulovesicular eruption. Although the pathogenesis of id reactions is uncertain, overactivation of T lymphocytes responding to the initial inflammatory insult has been implicated.7 A variety of noninfectious (eg, stasis dermatitis, contact dermatitis) and infectious dermatoses (eg, fungal, bacterial, viral, parasitic) may trigger id reactions.7,9-13 In this case, we believe an arthropod assault and/or reaction to the bandage adhesive was the primary insult, and the id reaction that ensued was so exuberant that it resulted not only in rupioid scale but also in peripheral eosinophilia—similar to how more severe forms of atopic dermatitis have been associated with peripheral eosinophilia.5 As such presentations of id reactions not have been widely described in the literature, this report expands our understanding of this condition to include rupioid scale and peripheral eosinophilia.

To the Editor:

In dermatology, rupioid describes ­dirty-appearing scale. The term is derived from the Greek word rhupos, which translates to “dirty” or “filthy.” This type of scale also is called ostraceous, owing to its resemblance to an oyster shell. Histopathologically, rupioid or ostraceous scale corresponds to epidermal hyperplasia and hyperkeratosis. Therefore, the presence of rupioid scale is believed to reflect an exuberant inflammatory response. Several dermatologic conditions have been associated with rupioid scale, including psoriasis, secondary syphilis, reactive arthritis, histoplasmosis, and Norwegian scabies.1-4 Peripheral eosinophilia has been reported in eczematous dermatoses such as atopic dermatitis and contact dermatitis,5,6 but our review of the literature did not find it described in the context of id reactions. We report the case of a patient who developed a rupioid id reaction with peripheral eosinophilia.

An otherwise healthy 40-year-old woman presented with a generalized pruritic eruption of 1 month’s duration. Prior to onset, she was bitten by a bug on the left arm and covered the site with a bandage. She subsequently noticed an erythematous papulopustular rash corresponding to the shape of the bandage adhesive. Shortly thereafter, a generalized eruption developed, prompting the patient to present for evaluation 1 month later. A review of systems was negative for fevers, chills, headaches, vision changes, and joint symptoms. She denied having a history of atopy.

Physical examination revealed numerous pink papules and plaques with rupioid scale scattered over the trunk and extremities (Figure). The palms, soles, and mucous membranes were spared. Laboratory studies revealed peripheral eosinophilia (9% eosinophils [reference range, 1%-6%] and an absolute eosinophil count of 600/µL [reference range, 0-400/µL]). A 3-mm punch biopsy of a representative lesion revealed a superficial perivascular infiltrate of lymphocytes, histiocytes, and eosinophils along with epidermal hyperplasia, spongiosis, and mounds of parakeratosis. Clinicopathologic correlation led to the diagnosis of a rupioid id reaction secondary to an arthropod assault and/or a reaction to the bandage adhesive.

CT117001014_e-FigAB
FIGURE. A and B, Rupioid id reaction secondary to an arthropod assault and/or a reaction to a bandage adhesive. Papules and plaques with rupioid scale were present on the back and left arm.

Treatment with topical corticosteroids was avoided at the patient’s request. Instead, a ceramide-based emollient and oral antihistamines (fexofenadine 180 mg in the morning and cetirizine 10 mg in the evening) were recommended and resulted in resolution of the eruption with postinflammatory hyperpigmentation at 2-week follow-up. The patient was advised to avoid further exposure to bandage adhesives.

An id reaction, or autoeczematization, is a cutaneous immunologic response to antigen(s) released from an initial, often distant site of inflammation.7,8 Clinically, it typically manifests as a pruritic, symmetrically distributed papulovesicular eruption. Although the pathogenesis of id reactions is uncertain, overactivation of T lymphocytes responding to the initial inflammatory insult has been implicated.7 A variety of noninfectious (eg, stasis dermatitis, contact dermatitis) and infectious dermatoses (eg, fungal, bacterial, viral, parasitic) may trigger id reactions.7,9-13 In this case, we believe an arthropod assault and/or reaction to the bandage adhesive was the primary insult, and the id reaction that ensued was so exuberant that it resulted not only in rupioid scale but also in peripheral eosinophilia—similar to how more severe forms of atopic dermatitis have been associated with peripheral eosinophilia.5 As such presentations of id reactions not have been widely described in the literature, this report expands our understanding of this condition to include rupioid scale and peripheral eosinophilia.

References
  1. Chung HJ, Marley-Kemp D, Keller M. Rupioid psoriasis and other skin diseases with rupioid manifestations. Cutis. 2014;94:119-121.
  2. Costa JB, de Sousa VLLR, da Trindade Neto PB, et al. Norwegian scabies mimicking rupioid psoriasis. An Bras Dermatol. 2012;87:910-913. doi:10.1590/S0365-05962012000600016
  3. Ip KH-K, Cheng HS, Oliver FG. Rupioid psoriasis. JAMA Dermatol. 2021;157:859. doi:10.1001/jamadermatol.2021.0451
  4. Wang Y, Wen Y. An AIDS patient with recurrent multiple skin crusted ulcerations. AIDS Res Hum Retroviruses. 2021;37:1-3. doi:10.1089/aid.2020.0212
  5. Staumont-Sallé D, Barbarot S, Bouaziz JD, et al. Effect of abrocitinib and dupilumab on eosinophil levels in patients with moderate-to-severe atopic dermatitis. JEADV Clin Pract. 2023;2:518-530. doi:10.1002/jvc2.192
  6. Savjani P. An unusual cause of eosinophilia—hypereosinophilia due to contact dermatitis. J Allergy Clin Immunol. 2016;137:AB168. doi:10.1016/j.jaci.2015.12.685
  7. Bertoli M, Schwartz RA, Janniger CK. Autoeczematization: a strange id reaction of the skin. Cutis. 2021;108:163-166. doi:10.12788/cutis.0342
  8. Ilkit M, Durdu M, Karakas¸ M. Cutaneous id reactions: a comprehensive review of clinical manifestations, epidemiology, etiology, and management. Crit Rev Microbiol. 2012;38:191-202. doi:10.3109/1040841X.2011.645520
  9. Brenner S, Wolf R, Landau M. Scabid: an unusual id reaction to scabies. Int J Dermatol. 1993;32:128-129. doi:10.1111/j.1365-4362.1993.tb01454.x
  10. Jordan L, Jackson NAM, Carter-Snell B, et al. Pustular tinea id reaction. Cutis. 2019;10:E3-E4.
  11. Crum N, Hardaway C, Graham B. Development of an idlike reaction during treatment for acute pulmonary histoplasmosis: a new cutaneous manifestation in histoplasmosis. J Am Acad Dermatol. 2003;48(2 suppl):S5-S6. doi:10.1067/mjd.2003.110
  12. Netchiporouk E, Cohen BA. Recognizing and managing eczematous id reactions to molluscum contagiosum virus in children. Pediatrics. 2012;129:e1072-e1075. doi:10.1542/peds.2011-1054
  13. Choudhri SH, Magro CM, Crowson AN, et al. An id reaction to Mycobacterium leprae: first documented case. Cutis. 1994;54:282-286.
References
  1. Chung HJ, Marley-Kemp D, Keller M. Rupioid psoriasis and other skin diseases with rupioid manifestations. Cutis. 2014;94:119-121.
  2. Costa JB, de Sousa VLLR, da Trindade Neto PB, et al. Norwegian scabies mimicking rupioid psoriasis. An Bras Dermatol. 2012;87:910-913. doi:10.1590/S0365-05962012000600016
  3. Ip KH-K, Cheng HS, Oliver FG. Rupioid psoriasis. JAMA Dermatol. 2021;157:859. doi:10.1001/jamadermatol.2021.0451
  4. Wang Y, Wen Y. An AIDS patient with recurrent multiple skin crusted ulcerations. AIDS Res Hum Retroviruses. 2021;37:1-3. doi:10.1089/aid.2020.0212
  5. Staumont-Sallé D, Barbarot S, Bouaziz JD, et al. Effect of abrocitinib and dupilumab on eosinophil levels in patients with moderate-to-severe atopic dermatitis. JEADV Clin Pract. 2023;2:518-530. doi:10.1002/jvc2.192
  6. Savjani P. An unusual cause of eosinophilia—hypereosinophilia due to contact dermatitis. J Allergy Clin Immunol. 2016;137:AB168. doi:10.1016/j.jaci.2015.12.685
  7. Bertoli M, Schwartz RA, Janniger CK. Autoeczematization: a strange id reaction of the skin. Cutis. 2021;108:163-166. doi:10.12788/cutis.0342
  8. Ilkit M, Durdu M, Karakas¸ M. Cutaneous id reactions: a comprehensive review of clinical manifestations, epidemiology, etiology, and management. Crit Rev Microbiol. 2012;38:191-202. doi:10.3109/1040841X.2011.645520
  9. Brenner S, Wolf R, Landau M. Scabid: an unusual id reaction to scabies. Int J Dermatol. 1993;32:128-129. doi:10.1111/j.1365-4362.1993.tb01454.x
  10. Jordan L, Jackson NAM, Carter-Snell B, et al. Pustular tinea id reaction. Cutis. 2019;10:E3-E4.
  11. Crum N, Hardaway C, Graham B. Development of an idlike reaction during treatment for acute pulmonary histoplasmosis: a new cutaneous manifestation in histoplasmosis. J Am Acad Dermatol. 2003;48(2 suppl):S5-S6. doi:10.1067/mjd.2003.110
  12. Netchiporouk E, Cohen BA. Recognizing and managing eczematous id reactions to molluscum contagiosum virus in children. Pediatrics. 2012;129:e1072-e1075. doi:10.1542/peds.2011-1054
  13. Choudhri SH, Magro CM, Crowson AN, et al. An id reaction to Mycobacterium leprae: first documented case. Cutis. 1994;54:282-286.
Issue
Cutis - 117(1)
Issue
Cutis - 117(1)
Page Number
E14-E15
Page Number
E14-E15
Publications
Publications
Topics
Article Type
Display Headline

Rupioid Id Reaction With Peripheral Eosinophilia

Display Headline

Rupioid Id Reaction With Peripheral Eosinophilia

Sections
Inside the Article

Practice Points

  • Consider a rupioid id reaction when a patient presents with lesions featuring scale that is dirty appearing and resembles an oyster shell.
  • Recognize that exuberant id reactions can manifest with peripheral eosinophilia; its presence should not lead you to automatically rule out an id reaction in favor of other eosinophilic eruptions.
  • Focus on uncovering the source of an id reaction (eg, contactants, infections, bites); resolving the primary insult is essential for rapid clearance of even dramatic rupioid eruptions.
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Un-Gate On Date
Use ProPublica
CFC Schedule Remove Status
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
survey writer start date